REGENERX.INVESTORROOM.COM HOST
I revealed that the main root page on regenerx.investorroom.com took one thousand four hundred and six milliseconds to download. We could not detect a SSL certificate, so therefore our parsers consider this site not secure.
Internet Protocol
64.78.159.10
SERVER OS AND ENCODING
I caught that regenerx.investorroom.com is implementing the Apache operating system.PAGE TITLE
RegeneRx Investors - OverviewDESCRIPTION
Pipeline Clinical Trials. To develop and commercialize novel pharmaceutical products that prevent or repair tissue and organ damage caused by disease, trauma, or other pathology. More. View Letter to Shareholders. Aug 12, 2015. New Publication Elaborates on TB4s Effects on Dry Eye Syndrome and Other Potential Ophthalmic Disorders. Aug 6, 2015. RegeneRx Provides Update on Clinical Trials in U.S., Korea and China. Jul 22, 2015. No events to display. July 15, 2014. July 7, 2014. June 23, 2014.CONTENT
This web page had the following in the homepage, "To develop and commercialize novel pharmaceutical products that prevent or repair tissue and organ damage caused by disease, trauma, or other pathology." We viewed that the web site stated " New Publication Elaborates on TB4s Effects on Dry Eye Syndrome and Other Potential Ophthalmic Disorders." It also said " RegeneRx Provides Update on Clinical Trials in U."